Document is current
Any future updates will be listed below
-
Authors
Wilde, Benjamin
- License Information
-
More Information
Article History
Accepted: 27 January 2023
First Online: 21 February 2023
Interessenkonflikt
: B. Wilde erhielt Kongressunterstützung und/oder Beraterhonorare von Alexion, Chiesi, GlaxoSmithKline, Hexal, Otsuka, Novartis, TEVA, Sanofi, Vifor und Wyeth.
